143 related articles for article (PubMed ID: 124592)
21. Mechanism of action of fibrinolytic enzymes in vivo.
Ambrus JL; Weber FJ; Ambrus CM
J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
[TBL] [Abstract][Full Text] [Related]
22. Oxidized fibrin stimulates the activation of pro-urokinase and is the preferential substrate of human plasmin.
Stief TW
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):117-21. PubMed ID: 8457638
[TBL] [Abstract][Full Text] [Related]
23. [Effects of heparin on plasmin and plasminogen activation].
Manmi S
Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):591-4. PubMed ID: 4261759
[No Abstract] [Full Text] [Related]
24. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
25. Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).
Fears R; Dodd I; Ferres H; Robinson JH
Biochem J; 1990 Mar; 266(3):693-6. PubMed ID: 2139324
[TBL] [Abstract][Full Text] [Related]
26. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
27. Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442.
Powell JR; Castellino FJ
J Biol Chem; 1980 Jun; 255(11):5329-35. PubMed ID: 6445361
[No Abstract] [Full Text] [Related]
28. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
29. Receptor for plasmin on human carcinoma cells.
Burtin P; Fondaneche MC
J Natl Cancer Inst; 1988 Jul; 80(10):762-5. PubMed ID: 2838642
[TBL] [Abstract][Full Text] [Related]
30. Activation of Glu-plasminogen by urokinase in the presence of fibrinogen, fibrin, and SK-potentiator.
Takada A; Takada Y
Thromb Res; 1981 May; 22(4):497-501. PubMed ID: 6457416
[No Abstract] [Full Text] [Related]
31. Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids.
Peltz SW; Hardt TA; Mangel WF
Biochemistry; 1982 May; 21(11):2798-804. PubMed ID: 6212078
[No Abstract] [Full Text] [Related]
32. Activation of plasminogen as a feature in its assay.
Gaffney PJ; Brasher M; Lord K; Kirkwood TB
Haemostasis; 1977; 6(1):72-88. PubMed ID: 140114
[TBL] [Abstract][Full Text] [Related]
33. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
34. Release of N-terminal peptides from Glu-plasminogen by plasmin in the presence of fibrin.
Takada A; Watahiki Y; Takada Y
Thromb Res; 1986 Mar; 41(6):819-27. PubMed ID: 2939588
[TBL] [Abstract][Full Text] [Related]
35. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
[TBL] [Abstract][Full Text] [Related]
36. Generation of kinin by plasma kallikrein and plasmin and the effect of alpha1-antitrypsin and antithrombin III on the kinongenases.
Habal FM; Burrowes CE; Movat HZ
Adv Exp Med Biol; 1976; 70(00):23-36. PubMed ID: 132848
[No Abstract] [Full Text] [Related]
37. The interaction between heparin and plasmin on amidolysis.
Kohn S; Sakurama S; Morioka T; Ito Y; Yasukouchi T; Nakagawa S
Thromb Haemost; 1979 Dec; 42(4):1261-75. PubMed ID: 161669
[TBL] [Abstract][Full Text] [Related]
38. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
Castro MJ; Kingston IB; Anderson S
Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
[TBL] [Abstract][Full Text] [Related]
39. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
40. Enhanced activity of plasmin and plasminogen activation in the presence of oleic acid.
Higazi AA; Mayer M
Ann N Y Acad Sci; 1992 Dec; 667():81-3. PubMed ID: 1309074
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
